Evidence map›Paper›PMID 38617358›Full record

ArticlebioRxiv : the preprint server for biology2024

Na

Junior Gonzales, Dauren Adilbay, Paula Demetrio de Souza Franca, Raik Artschwager, Chun Yuen Chow, Tara Viray, Delissa S Johnson, Yan Jiang, Snehal G Patel, Ian Ganly and 5 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Junior GonzalesDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Dauren AdilbayDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.ORCID 0000-0002-5555-2019
Paula Demetrio de Souza FrancaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Raik ArtschwagerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Chun Yuen ChowInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
Tara VirayDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Delissa S JohnsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Yan JiangInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
Snehal G PatelDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Ian GanlyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Christina I SchroederInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
Jason S LewisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Glenn F KingInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
Thomas ReinerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Nagavarakishore PillarsettyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.ORCID 0000-0002-1750-7436
Memorial Sloan Kettering Cancer Center · USAustralian Research Council · AUThe University of Queensland · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Leveraging Pb-203/212 for the Theranostic Imaging and Therapy of Prostate CancerR35CA232130 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LEWIS, JASON S. · 2019 to 2025
$8.2M
Development and validation of an intraoperative imaging agent for the peripheral nervous systemR01EB029769 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI PILLARSETTY, NAGAVARAKISHORE · 2020 to 2023
$2.2M
Validation of an Intraoperative Neuro-Monitoring Contrast Agent for Cranial NervesR00GM145587 · NIGMS · CLEVELAND STATE UNIVERSITY · PI GONZALES-AREVALO, JUNIOR ARTURO · 2023 to 2023
$249k
NCI NIH HHS P30 CA008748NCI NIH HHS R35 CA232130NIBIB NIH HHS R01 EB029769NIGMS NIH HHS R00 GM145587
6 · The paper itself

Abstract

Surgeries and trauma result in traumatic and iatrogenic nerve damage that can result in a debilitating condition that approximately affects 189 million individuals worldwide. The risk of nerve injury during oncologic surgery is increased due to tumors displacing normal nerve location, blood turbidity, and past surgical procedures, which complicate even an experienced surgeon's ability to precisely locate vital nerves. Unfortunately, there is a glaring absence of contrast agents to assist surgeons in safeguarding vital nerves. To address this unmet clinical need, we leveraged the abundant expression of the voltage-gated sodium channel 1.7 (Na

Identifiers

PMID38617358
PMCPMC11014580
OpenAlexW4394063159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.